Marinus Pharmaceuticals (MRNS) PT Raised to $3 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Marinus Pharma (MRNS) Reports Q2 Loss of $0.46
August 9, 2016 4:25 PM EDTMarinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.46), versus ($0.37) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.
... More


